Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function

The development of liposomal delivery technology has been a game-changer for oral glutathione supplementation. This pilot study by Sinha, Sinha, Calcagnotto, and colleagues, published in the European Journal of Clinical Nutrition, demonstrated just how effective this delivery method can be.

The researchers administered liposomal glutathione to 12 healthy adults for 4 weeks and measured GSH levels across multiple body compartments, along with immune function markers and oxidative stress biomarkers. The liposomal formulation encapsulates glutathione in phospholipid vesicles that protect it from digestive breakdown.

The results exceeded expectations. Whole blood glutathione rose by 40%, plasma levels by 28%, and peripheral blood mononuclear cell (PBMC) levels by 100% — all within just 2 weeks. The immune effects were even more dramatic: NK cell cytotoxicity increased up to 400% and lymphocyte proliferation rose up to 60%. Plasma 8-isoprostane, a marker of oxidative damage, dropped by 35%.

This study validates liposomal glutathione as a practical and highly effective oral delivery method. The rapid onset of action (2 weeks), combined with the dramatic improvements in both immune function and oxidative stress, makes liposomal GSH one of the most impactful supplements available for immune optimization and antioxidant defense.